The Liver Biopsy Market, valued at USD 5505.71 million in 2023, is projected to reach USD 9249.79 million by 2031, with a 6.7% CAGR from 2024 to 2031. This growth is driven by increasing liver disease incidences, necessitating accurate diagnostic procedures. Advancements in imaging and biopsy techniques enhance safety and efficiency, while rising awareness and healthcare infrastructure expansion fuel market expansion.